[
    [
        {
            "time": "2021-12-31",
            "original_text": "Biotech Stocks That Soared in 2021 and Could Go Even Higher in 2022",
            "features": {
                "keywords": [
                    "biotech",
                    "soared",
                    "higher"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Biotech Stocks That Soared in 2021 and Could Go Even Higher in 2022",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2022-01-04",
            "original_text": "Putnam Asset Allocation Funds Buys Anthem Inc, Moderna Inc, Target Corp, Sells Procter & ...",
            "features": {
                "keywords": [
                    "asset allocation",
                    "buys",
                    "sells",
                    "Anthem",
                    "Moderna",
                    "Target",
                    "Procter"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "retail",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Putnam Asset Allocation Funds Buys Anthem Inc, Moderna Inc, Target Corp, Sells Procter & ...",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2022-01-05",
            "original_text": "Will Eli Lilly Be a Top Pharma Stock Again in 2022?",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "pharma",
                    "top stock"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Will Eli Lilly Be a Top Pharma Stock Again in 2022?",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]